Detalles de la búsqueda
1.
The WHOQOL-BREF instrument: Psychometric evaluation of the Greek version in patients with advanced cancer and pain and associations with psychological distress.
Palliat Support Care
; : 1-11, 2022 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983635
2.
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
Oncologist
; 26(5): e769-e779, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33687747
3.
AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study.
Acta Oncol
; 60(6): 785-793, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003074
4.
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Cancer Immunol Immunother
; 69(8): 1549-1564, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303794
5.
The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature.
Contemp Oncol (Pozn)
; 24(1): 75-78, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514241
6.
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.
Br J Cancer
; 119(3): 303-312, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30013091
7.
Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients.
J Hum Genet
; 63(8): 877-886, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29785007
8.
Identification of catheter misplacement in early port CVC dysfunction.
Contemp Oncol (Pozn)
; 22(2): 129-134, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30150892
9.
Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
J Transl Med
; 15(1): 30, 2017 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193231
10.
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.
Breast Cancer Res Treat
; 158(2): 307-21, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27369359
11.
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
J Transl Med
; 14(1): 136, 2016 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184134
12.
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
J Transl Med
; 13: 171, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021752
13.
Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary.
Eur J Clin Invest
; 45(11): 1145-52, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26269154
14.
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
BMC Cancer
; 15: 384, 2015 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25956750
15.
Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancer.
Support Care Cancer
; 23(7): 2045-51, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25524005
16.
Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.
Strahlenther Onkol
; 190(7): 636-8, 640-5, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24658605
17.
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
BMC Cancer
; 14: 111, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24555920
18.
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.
BMC Clin Pathol
; 14: 28, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24987308
19.
Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide.
J BUON
; 19(3): 718-23, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25261658
20.
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.
Mol Cancer
; 12: 57, 2013 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23758919